Back

Increased risk of supraventricular tachycardia with polycystic ovarian syndrome

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Supraventricular tachycardia Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Kavin Raj

University of California Riverside, Riverside (United States of America)

6 More presentations in this session

Presentation thumbnail
A novel method to identify critical isthmus of right atrial reentrant tachycardia; Functional substrate mapping characteristics during sinus rhythm
Doctor S. Kilic (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Transbaffle or retrograde aortic approach for atrial arrhythmias ablation in patients with D-TGA treated with atrial switch surgery.
Doctor J. Francisco Pascual (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Is the conventional deployment of electrode catheters appropriate to diagnose the circuit of atypical atrioventricular nodal reentrant tachycardia? -New insights into the retrograde slow pathways-
Doctor M. Kawabata (Kawasaki, JP)
Abstract Slides Video
Presentation thumbnail
SLAM-guided catheter ablation of AVNRT: single-center experience
Doctor E. Gul (Konya, TR)
Abstract Slides Video
Presentation thumbnail
Differential right apical and left basal pacing: a new maneuver that rules out the presence of a left accessory pathway with retrograde conduction.
Doctor M. Martinez Cossiani (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Supraventricular tachycardia

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Women with polycystic ovarian syndrome are at increased associated risk of acute myocardial infarction and ischemic stroke
thumbnail
Congress Presentation
Risk of death and thromboembolic events in patients with supraventricular arrhythmias admitted to the emergency department.
thumbnail
Congress Presentation
Risk factors and prediction model for hypertension in women with hyperandrogenic phenotypes of polycystic ovary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources